Search results
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 2 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 3 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoA Novavax spokesperson said that the later meeting date “will not affect Novavax’s ability to...
Iran's new president's link to COVID vaccine
Newsweek· 5 days agoNew interim Iranian President Mohammad Mokhber received scrutiny for his role in the lack of development of a domestic vaccine at the height of the COVID
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 4 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 7 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 3 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known ...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 2 days agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 3 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID